Leukotrienes in asthma and allergic rhinitis

Editorial

D J Stechschulte. N Engl J Med. 1990.

. 1990 Dec 20;323(25):1769-70.

doi: 10.1056/NEJM199012203232511.

No abstract available

Comment on

Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor.
Knapp HR. Knapp HR. N Engl J Med. 1990 Dec 20;323(25):1745-8. doi: 10.1056/NEJM199012203232506. N Engl J Med. 1990. PMID: 1701029 Clinical Trial.
Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
Manning PJ, Watson RM, Margolskee DJ, Williams VC, Schwartz JI, O'Byrne PM. Manning PJ, et al. N Engl J Med. 1990 Dec 20;323(25):1736-9. doi: 10.1056/NEJM199012203232504. N Engl J Med. 1990. PMID: 2174121 Clinical Trial.
The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air.
Israel E, Dermarkarian R, Rosenberg M, Sperling R, Taylor G, Rubin P, Drazen JM. Israel E, et al. N Engl J Med. 1990 Dec 20;323(25):1740-4. doi: 10.1056/NEJM199012203232505. N Engl J Med. 1990. PMID: 2247106 Clinical Trial.